Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 1.00 |
| ▸ | CTSS | P25774 | 11/20 | 0.64 |
| ▸ | CTSK | P43235 | 10/20 | 0.64 |
| ▸ | CTSB | P07858 | 4/20 | 0.64 |
| ▸ | CTSL | P07711 | 2/20 | 0.64 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.52 |
| ▸ | ACE | P12821 | 1/20 | 0.51 |
| ▸ | CCKAR | P32238 | 1/20 | 0.50 |
| ▸ | CCKBR | P32239 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22915441 | 0.91 | AKT1 (0.83) | AKT1CTSSCTSKCTSBCTSL | |
| SCHEMBL28767105 | 0.91 | AKT1 (0.83) | AKT1CTSSCTSKCTSBCTSL | |
| SCHEMBL20204230 | 0.90 | AKT1 (0.82) | AKT1CTSSCTSKCTSBCTSL | |
| SCHEMBL21010315 | 0.86 | CTSS (0.79) | AKT1CTSSCTSKCTSBCTSL | |
| SCHEMBL2440946 | 0.86 | CTSS (0.79) | AKT1CTSSCTSKCTSBCTSL | |
| SCHEMBL2442760 | 0.84 | CTSS (0.76) | AKT1CTSSCTSKCTSBCTSL | |
| SCHEMBL2446582 | 0.84 | CTSS (0.76) | AKT1CTSSCTSKCTSBCTSL | |
| SCHEMBL22915399 | 0.83 | AKT1 (0.71) | AKT1CTSSCTSKCTSBCTSL | |
| SCHEMBL22915374 | 0.83 | AKT1 (0.71) | AKT1CTSSCTSKCTSBCTSL | |
| SCHEMBL2405030 | 0.83 | CTSS (0.74) | AKT1CTSSCTSKCTSBCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3778653-B1 | NOVEL REACTIVE ALGINIC ACID DERIVATIVES | MOCHIDA PHARM CO LTD (JP) | 2025-07-09 | — | — | EP | disclosed |
| US-20220396643-A1 | NOVEL CROSSLINKED ALGINIC ACID STRUCTURE | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2022-12-15 | — | — | US | disclosed |
| US-11472892-B2 | Reactive alginic acid derivatives | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2022-10-18 | — | — | US | disclosed |
| US-11472892-B2 | Reactive alginic acid derivatives | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2022-10-18 | — | — | US | disclosed |
| WO-2021060336-A1 | NOVEL CROSSLINKED ALGINIC ACID STRUCTURE | 持田製薬株式会社 | 2021-04-01 | — | — | WO | disclosed |
| EP-3778653-A1 | NOVEL REACTIVE ALGINIC ACID DERIVATIVES | Mochida Pharmaceutical Co., Ltd. (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20210024659-A1 | NOVEL REACTIVE ALGINIC ACID DERIVATIVES | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2021-01-28 | — | — | US | disclosed |